@pillowtalk222's low T and sex drive claims, fact-checked

What did @pillowtalk222 actually say?

The creator walked through what she describes as the first symptom of low testosterone in women: low to no libido. She drew a distinction between situational exhaustion, being a tired mom, a student, someone working full time, and what she called "true libido issues." Her definition: "no desire, meaning your brain is not going, oh, it would be good to have sex," combined with physical non-responsiveness even when a partner initiates. She framed this from personal experience, noting "that is how this looks when I had low T."

That framing matters. She is not presenting a clinical diagnosis. She is presenting a symptom pattern through the lens of her own history, while also drawing a line between fatigue-driven low interest and something more pervasive. The distinction she is making is clinically meaningful, even if she is not using clinical language to make it.

Does the science back this up?

Largely, yes, though with some important caveats. Testosterone does play a role in female sexual desire, and hypoactive sexual desire disorder (HSDD) is a real, recognized condition. The connection between low androgen levels and reduced libido in women has been studied, though the evidence is messier than TikTok tends to suggest.

A 2019 international consensus statement published in the Journal of Clinical Endocrinology and Metabolism (Davis et al.) concluded that testosterone therapy improves sexual function in postmenopausal women, specifically desire, arousal, and orgasm. That said, the statement also noted that diagnosing low testosterone in women based on symptoms alone is not reliable because serum testosterone levels do not consistently correlate with symptoms. The International Society for the Study of Women's Sexual Health has also published position statements acknowledging libido as an androgen-sensitive function in women, while cautioning against over-medicalization.

The creator's two-part description, absent mental desire plus absent physical response, maps reasonably well onto how clinicians assess HSDD: both subjective desire and genital arousal response are considered in diagnosis.

What did they get wrong (or right)?

She got the conceptual split between fatigue-driven and hormonally-driven low libido right. That is a real and clinically relevant distinction. Clinicians do try to tease apart situational, relationship-based, and physiological contributors to low desire, and testosterone is one piece of that picture.

What she skips over is that low testosterone is far from the only, or even the most common, driver of low libido in women. Depression, antidepressants (particularly SSRIs), relationship dynamics, prior trauma, thyroid dysfunction, and perimenopause-related estrogen shifts all independently suppress desire. Attributing "no desire" to low T without ruling those out first is a significant clinical leap.

She also does not mention that testosterone testing in women is notoriously inconsistent. Commercial assays are not validated for the lower testosterone ranges typical in women (Handelsman et al., 2017, Andrology). A woman can feel exactly as she described and have testosterone levels in the normal reference range, because those ranges are poorly defined for female physiology in the first place.

Credit where it is due: she did not tell anyone to self-diagnose or start a supplement. She shared her own experience as a reference point, which is a more honest framing than a lot of what circulates in this space.

What should you actually know?

Low libido in women is real, common, and undertreated. Testosterone does appear to be one lever in female sexual function. The 2019 Davis et al. consensus paper is the most cited evidence base here, and it does support a link between androgen levels and sexual desire, particularly in postmenopausal women. The data in premenopausal women is thinner.

If you recognize yourself in what the creator describes, that is worth bringing to a clinician, but the conversation should not start and end with testosterone. A thorough workup would look at thyroid function, mood, medications, relationship context, and hormone panels interpreted by someone who understands the limits of female testosterone assays.

The FDA has not approved any testosterone product specifically for women in the United States. That does not mean it is never prescribed off-label, but it does mean the regulatory evidence bar has not been cleared the way it has for male hypogonadism. That is context anyone considering treatment deserves to have upfront.